Advertisement

Digestive Diseases and Sciences

, Volume 50, Supplement 1, pp S90–S96 | Cite as

Rebamipide Reduces Recurrence of Experimental Gastric Ulcers: Role of Free Radicals and Neutrophils

  • Kazushi SakuraiEmail author
  • Toshihiro Osaka
  • Katsuya Yamasaki
Article

Abstract

Mucosal inflammation is a crucial factor for the recurrence of peptic ulcer. In this study, we examined the effect of rebamipide on neutrophils infiltration, lipid peroxidation, and antioxidative enzyme activities in the recurrence of experimental gastric ulcer. Ulcer recurrence was examined at 60, 100, and 140 days after production of acetic acid-induced gastric ulcers in rats. Gastric neutrophil infiltration, lipid peroxidation, and antioxidative enzyme activities were determined by analyses of myeloperoxidase (MPO) activity, thiobarbituric acid reactive substance (TBARS) levels, and glutathione peroxidase (GSHpx) and superoxide dismutase (SOD) activities in the ulcer region, respectively. The effect of rebamipide, an antigastric-ulcer agent, on ulcer recurrence was assessed following oral administration at 60 mg/kg/day from day 20. In the control and rebamipide groups, gastric ulcer indices were reduced on day 100 compared with day 60; however, increases were observed on day 140, indicating ulcer recurrence. In the rebamipide group, the ulcer index was smaller than in the control group at each time point and the effect was significant on day 140. Although marked elevation of MPO activities was observed in the control group during the experiment, no significant elevations were seen in the rebamipide group on days 100 and 140. TBARS levels were significantly elevated in the control group on day 140, but not in the rebamipide group. Rebamipide suppressed the decrease in GSHpx activity on day 60. These results suggest that lipid peroxidation of gastric tissue mediated by free radicals from neutrophils is responsible for the recurrence of acetic acid-induced gastric ulcers in rats, and that the elimination of free radicals by rebamipide may contribute to the reduction of severity in ulcer recurrence.

Key Words

acetic acid-induced ulcer ulcer recurrence neutrophils free radicals rebamipide 

References

  1. 1.
    Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, Phillips M, Waters TE, Sanderson CR: Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 2:1437–1442, 1988CrossRefPubMedGoogle Scholar
  2. 2.
    Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ Jr, Saeed ZA, Malaty HM: Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 116:705–708, 1992PubMedGoogle Scholar
  3. 3.
    Miwa H, Sakaki N, Sugano K, Sekine H, Higuchi K, Uemura N, Kato M, Murakami K, Kato C, Shiotani A, Ohkusa T, Takagi A, Aoyama N, Haruma K, Okazaki K, Kusugami K, Suzuki M, Joh T, Azuma T, Yanaka A, Suzuki H, Hashimoto H, Kawai T, Sugiyama T: Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients. Helicobacter 9:9–16, 2004CrossRefPubMedGoogle Scholar
  4. 4.
    Graham DY, Agrawal NM, Campbell DR, Haber MM, Collis C, Lukasik NL, Huang B: NSAID-Associated Gastric Ulcer Prevention Study Group: Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs. lansoprazole. Arch Intern Med 162:169–175, 2002CrossRefGoogle Scholar
  5. 5.
    Takagi K, Okabe S, Saziki R: A new method for the production of chronic gastric ulcer in rats and the effect of several drugs on its healing. Jpn J Pharmacol 19:418–426, 1969PubMedGoogle Scholar
  6. 6.
    Fukawa K, Kawano O, Misaki N, Uchida M, Irino O: Experimental studies on gastric ulcer (4). Sequential observation and evaluation of gastric ulcers by endoscope in the rat. Jpn J Pharmacol 33:175–179, 1983PubMedGoogle Scholar
  7. 7.
    Salim AS: Oxygen-derived free radicals and the prevention of duodenal ulcer relapse: a new approach. Am J Med Sci 300:1–6, 1990PubMedGoogle Scholar
  8. 8.
    Bhattacharjee M, Bhattacharjee S, Gupta A, Banerjee RK: Critical role of an endogenous gastric peroxidase in controlling oxidative damage in H. pylori-mediated and nonmediated gastric ulcer. Free Radic Biol Med 32:731–743, 2002CrossRefPubMedGoogle Scholar
  9. 9.
    Satoh K, Kimura K, Yoshida Y, Kasano T, Kihira K, Taniguchi Y: A topographical relationship between Helicobacter pylori and gastritis: quantitative assessment of Helicobacter pylori in the gastric mucosa. Am J Gastroenterol 86:285–291, 1991PubMedGoogle Scholar
  10. 10.
    Dixon MF: Pathophysiology of Helicobacter pylori infection. Scand J Gastroenterol 201(Suppl):7–10, 1994Google Scholar
  11. 11.
    Watanabe T, Arakawa T, Fukuda T, Higuchi K, Kobayashi K: Role of neutrophils in a rat model of gastric ulcer recurrence caused by interleukin-1β. Am J Pathol 150:971–979, 1997PubMedGoogle Scholar
  12. 12.
    Takahashi S, Keto Y, Fujita H, Muramatsu H, Nishino T, Okabe S: Pathological changes in the formation of Helicobacter pylori-induced gastric lesions in Mongolian gerbils. Dig Dis Sci 43(4):754–765, 1998CrossRefPubMedGoogle Scholar
  13. 13.
    Vaananen PM, Meddings JB, Wallace JL: Role of oxygen-derived free radicals in indomethacin-induced gastric injury. Am J Physiol 261:G470–G475, 1991PubMedGoogle Scholar
  14. 14.
    Naito Y, Yoshikawa T, Ando T, Kishi A, Ueda S, Oyamada H, Kondo M: Changes in superoxide dismutase activity in the gastric mucosa of peptic ulcer patients. J Clin Gastroenterol 14:S131–S134, 1992PubMedGoogle Scholar
  15. 15.
    Hirokawa K, Kawasaki H: Changes in glutathione in gastric mucosa of gastric ulcer patients. Res Commun Mol Pathol Pharmacol 88(2):163–176, 1995PubMedGoogle Scholar
  16. 16.
    Oshima A, Asayama K, Sakai N, Kitajima M: The role of endogenous free radical scavengers on tissue recovery in the experimental ulcer model. J Clin Gastroenterol 12:S58–S64, 1990PubMedGoogle Scholar
  17. 17.
    Yamasaki K, Ishiyama H, Imaizumi T, Kanbe T, Yabuuchi Y: Effect of OPC-12759, a novel antiulcer agent, on chronic and acute experimental gastric ulcer, and gastric secretion in rats. Jpn J Pharmacol 49:441–448, 1989PubMedGoogle Scholar
  18. 18.
    Arakawa T, Watanabe T, Fukuda T, Yamasaki K, Kobayashi K: Rebamipide, novel prostaglandin-inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer. Comparison with cimetidine. Dig Dis Sci 40:2469–2472, 1995CrossRefPubMedGoogle Scholar
  19. 19.
    Tarnawski A, Arakawa T, Kobayashi K: Rebamipide treatment activates epidermal growth factor and its receptor expression in normal and ulcerated gastric mucosa in rats: one mechanism for its ulcer healing action? Dig Dis Sci 43:90S–98S, 1998CrossRefPubMedGoogle Scholar
  20. 20.
    Udagawa A, Shiota G, Ichiba M, Murawaki Y: Effect of rebamipide on acetic acid-induced gastric ulcer in rats: involvement of hepatocyte growth factor. Scand J Gastroenterol 38:141–146, 2003PubMedGoogle Scholar
  21. 21.
    Yoshikawa T, Naito Y, Tanigawa T, Kondo M: Free radical scavenging activity of the novel antiulcer agent rebamipide studied by electron spin resonance. Arzneimittelforschung 43:363–366, 1993PubMedGoogle Scholar
  22. 22.
    Naito Y, Yoshikawa T, Tanigawa T, Sakurai K, Yamasaki K, Uchida M, Kondo M: Hydroxyl radical scavenging by rebamipide and related compounds: electron paramagnetic resonance study. Free Radic Biol Med 18:117–123, 1995CrossRefPubMedGoogle Scholar
  23. 23.
    Sakurai K, Sasabe H, Koga T, Konishi T: Mechanism of hydroxyl radical scavenging by rebamipide: identification of mono-hydroxylated rebamipide as a major reaction product. Free Radic Res 38:487–494, 2004CrossRefPubMedGoogle Scholar
  24. 24.
    Ogino K, Hobara T, Ishiyama H, Yamasaki K, Kobayashi H, Izumi Y, Oka S: Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats. Eur J Pharmacol 212:9–13, 1992CrossRefPubMedGoogle Scholar
  25. 25.
    Suzuki M, Miura S, Mori M, Kai A, Suzuki H, Fukumura D, Suematsu M, Tsuchiya M: Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants. Gut 35:1375–1378, 1994PubMedGoogle Scholar
  26. 26.
    Nagano C, Azuma A, Ishiyama H, Sekiguchi K, Imagawa K, Kikuchi M: Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils. J Pharmacol Exp Ther 297:388–394, 2001PubMedGoogle Scholar
  27. 27.
    Yamasaki K, Kanbe T, Chijiwa T, Ishiyama H, Morita S: Gastric mucosal protection by OPC-12759, a novel antiulcer compound, in the rat. Eur J Pharmacol 142:23–29, 1987CrossRefPubMedGoogle Scholar
  28. 28.
    Kleine A, Kluge S, Peskar BM: Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats. Dig Dis Sci 38:1441–1449, 1993CrossRefPubMedGoogle Scholar
  29. 29.
    Sun WH, Tsuji S, Tsujii M, Gunawan ES, Kawai N, Kimura A, Kakiuchi Y, Yasumaru M, Iijima H, Okuda Y, Sasaki Y, Hori M, Kawano S: Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent. J Pharmacol Exp Ther 295:447–452, 2000PubMedGoogle Scholar
  30. 30.
    Krawisz JE, Sharon P, Stenson WF: Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87:1344–1350, 1984PubMedGoogle Scholar
  31. 31.
    Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358, 1979CrossRefPubMedGoogle Scholar
  32. 32.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RL: Protein measurements with the Folin phenol reagent. J Biol Chem 193:265–275, 1951PubMedGoogle Scholar
  33. 33.
    Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169, 1967PubMedGoogle Scholar
  34. 34.
    Oyanagui Y: Reevaluation of assay methods and establishment of kit for superoxide dismutase activity. Anal Biochem 142:290–296, 1984CrossRefPubMedGoogle Scholar
  35. 35.
    Valle J, Seppala K, Sipponen P, Kosunen T: Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study. Scand J Gastroenterol 26:1057–1065, 1991Google Scholar
  36. 36.
    Malfertheiner P, Bayerdorffer E, Diete U, Gil J, Lind T, Misiuna P, O'Morain C, Sipponen P, Spiller RC, Stasiewicz J, Treichel H, Ujszaszy L, Unge P, Zanten SJ, Zeijlon L: The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther 13:703–712, 1999CrossRefPubMedGoogle Scholar
  37. 37.
    Wallace JL, MacNaughton WK, Morris GP, Beck PL: Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 96:29–36, 1989PubMedGoogle Scholar
  38. 38.
    Yoshida N, Yoshikawa T, Nakamura Y, Arai M, Matsuyama K, Iinuma S, Yagi N, Naito Y, Miyasaka M, Kondo M: Role of neutrophil-mediated inflammation in aspirin-induced gastric mucosal injury. Dig Dis Sci 40:2300–2304, 1995CrossRefPubMedGoogle Scholar
  39. 39.
    Sakurai K, Yamasaki K: Protective effect of rebamipide against hydrogen peroxide-induced hemorrhagic mucosal lesions in rat stomach. Jpn J Pharmacol 64:229–234, 1994PubMedGoogle Scholar
  40. 40.
    Aihara M, Azuma A, Takizawa H, Tsuchimoto D, Funakoshi Y, Shindo Y, Ohmoto Y, Imagawa K, Kikuchi M, Mukaida N, Matsushima K: Molecular analysis of suppression of interleukin-8 production by rebamipide in Helicobacter pylori-stimulated gastric cancer cell lines. Dig Dis Sci 43:174S–180S, 1998PubMedGoogle Scholar
  41. 41.
    Watanabe T, Higuchi K, Tominaga K, Fujiwara Y, Arakawa T: Acid regulates inflammatory response in a rat model of induction of gastric ulcer recurrence by interleukin 1β. Gut 48:774–781, 2001CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Kazushi Sakurai
    • 1
    Email author
  • Toshihiro Osaka
    • 2
  • Katsuya Yamasaki
    • 3
  1. 1.Free Radical Research InstituteOtsuka Pharmaceutical Co., Ltd.TokushimaJapan
  2. 2.Third Institute of New Drug DiscoveryOtsuka Pharmaceutical Co., Ltd.TokushimaJapan
  3. 3.Pharmaceutical Business DivisionOtsuka Pharmaceutical Co., Ltd.TokushimaJapan

Personalised recommendations